REG - Volex PLC - Appointment of New Director

VolexAnnouncement

30/07/2019 16:50

RNS Number : 2588H
Volex PLC
30 July 2019
 


30 July 2019
 
Volex plc
("Volex" or the "Company")
 
Appointment of new director
 
Volex, the global supplier of complex assemblies for performance critical applications and power products, is pleased to confirm that following his election at its Annual General Meeting today, Jeffrey Jackson has been appointed as a non-executive director of the Company, effective immediately.
 
A former Global Category Manager for Smith & Nephew plc, Jeffrey Jackson is currently employed as Transitions Leader at Meggitt plc and will bring additional expertise in operations and supply chain management to the Board.
 
Executive Chairman Nat Rothschild welcomed the appointment:
 
"I am delighted to welcome Jeffrey to the board of the Company and look forward to working with him as we build on Volex's recent success and continue to deliver on our business strategy. He will bring valuable operational experience to the Company and additional oversight to the work of the Board."
 
Jeffrey Marc Jackson, aged 67, has not been a director or partner in any company or partnership in the last five years, and there is no other information that needs to be disclosed under AIM Rule 17 and Schedule 2(g). He does not currently own any shares in the Company.
 
Enquiries
For further information please contact: 
 
 
Volex plc                                                                                                            +44 7909 995 887
Nat Rothschild, Executive Chairman
Daren Morris, Chief Financial Officer and Company Secretary
 
N+1 Singer - Nominated Adviser & Joint Broker                                       +44 20 7496 3000
Shaun Dobson
 
Whitman Howard - Joint Broker                                                                  +44 20 7659 1234
Hugh Rich
Nick Lovering




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABUGDRSSXBGCG